Literature DB >> 2857989

Use of enoxacin in a patient with cystic fibrosis.

M G Miller, A T Ghoneim, J M Littlewood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2857989     DOI： 10.1016/s0140-6736(85)92192-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Clinical uses of nalidixic acid analogues: the fluoroquinolones.

Authors:  N Høiby
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

Review 2.  An overview of the management of cystic fibrosis.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

Review 3.  High dose treatment with antibiotics in cystic fibrosis--a reappraisal with special reference to the pharmacokinetics of beta-lactams and new fluoroquinolones in adult CF-patients.

Authors:  F Sörgel; U Stephan; H G Wiesemann; B Gottschalk; C Stehr; M Rey; H B Böwing; H C Dominick; M Geldmacher von Mallinckrodt
Journal:  Infection       Date:  1987       Impact factor: 3.553

Review 4.  [Cartilage-damaging effect of quinolones].

Authors:  R Stahlmann
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 5.  Clinical overview of enoxacin.

Authors:  S H Zinner
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.